Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, June 26, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Bradley Canino Maintained (SNDX) at Strong Buy with Increased Target to $42 on, Jun 26th, 2024
Bradley Canino of Stifel, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Increased Target from $40 to $42 on, Jun 26th, 2024.
Bradley has made no other calls on SNDX in the last 4 months.
There are 3 other peers that have a rating on SNDX. Out of the 3 peers that are also analyzing SNDX, 0 agree with Bradley's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Bradley
- Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $41 on, Monday, June 17th, 2024
- Anupam Rama of "JP Morgan" Maintained at Buy and Held Target at $34 on, Tuesday, May 21st, 2024
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $30 on, Thursday, May 9th, 2024
